Dawn Svoronos, Director at Adverum Biotechnologies, Inc. (ADVM), bought 30,000 shares at $0.85 ($26K) on 2022-05-16, disclosed to the SEC on 2022-05-18.
Open-market purchase of $26k ADVM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| GBT | SELL | 2022-06-22 | $104K | — | Filing → |
| PTCT | SELL | 2022-06-10 | $20K | — | Filing → |
| PTCT | SELL | 2022-01-11 | $20K | — | Filing → |